How Effective Is Moderna After First Dose

Moderna Says FDA Will Consider Its New Flu Shot

Moderna says the FDA will consider its new flu shot after resolving a public dispute

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot.

· 14h · on MSN

FDA reverses course and will review Moderna’s mRNA-based flu shot

Opinion

· 6d · on MSN

Clinical trials show Moderna's new mRNA flu vaccine is safe and effective. FDA won't even consider it

· 4h

Opinion: An anti-science FDA is a threat to our health and prosperity

The U.S. Food and Drug Administration supposedly “ implements gold standard science .”

· 11h

Moderna stock surges as FDA reverses course, agrees to review new flu shot

· 11h

US FDA reverses course, will review Moderna's revised flu vaccine application

The Business Journals

Trial of Moderna’s flu vaccine proves more effective than standard-dose shot in trial

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Cambridge drug and vaccine ...

The BulwarkOpinion

This Is What Destroying the Vaccine Market Looks Like

THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government. A potentially groundbreaking vaccine for seasonal flu that the Massachusetts-based company had developed would not be getting approval from regulators.

How we tracked Covid updates

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver College of Medicine and a member of the U.S. Food and Drug Administration’s (FDA) vaccine advisory committee, and Angela Shen, a visiting scientist with the Vaccine Education Center at Children’s Hospital of Philadelphia.